Accera Inc., of Broomfield, Colo., appointed Dean Taylor vice president, business development.
Access Pharmaceuticals Inc., of Dallas, appointed Mark Ahn to its board.
Adolor Corp., of Exton, Pa., appointed Richard Mangano vice president, clinical operations.
Alexza Pharmaceuticals Inc., of Palo Alto, Calif., appointed Michael Taylor vice president, preclinical development.
Ambrilia Biopharma Inc., of Montreal, appointed Luc Tanguay to its board.
AMDL Inc., of Tustin, Calif., appointed Akio Ariura chief financial officer.
Arcxis Biotechnologies, of Pleasanton, Calif., appointed Howard Goldstein president and CEO.
Avantogen Oncology Inc., of Los Angeles, appointed Angela Bronow Davanzo chief financial officer.
BioDelivery Sciences International Inc., of Morrisville, N.C., appointed Thomas D'Alonzo to its board.
Biomira Inc., of Edmonton, Alberta, appointed Robert Kirkman president and CEO, and Christopher Henney chairman.
Biota Holdings Ltd., of Melbourne, Australia, appointed Paul Bell nonexecutive director.
Caliper Life Sciences Inc., of Hopkinton, Mass., appointed Peter Lassota divisional vice president of oncology.